YuMOVE Joint Care vs Cosequin DS Plus MSM

Side-by-side pages should help you weigh tradeoffs, not crown a vague winner.

Two top-scoring dog joint supplements, head to headPartial-source beta data

YuMOVE

Joint Care for Adult Dogs

7.9/ 10

Leads on PetScored rating, Evidence Quality, Safety & Manufacturing

Find on Amazon
VS

YuMOVE edges Nutramax by 0.2 on composite.

+0.2 composite

Nutramax

Cosequin DS Plus MSM Chewable Tablets

7.7/ 10

Leads on Active Dose

Find on Amazon

Affiliate links. We may earn a commission; it never affects the score. See our affiliate disclosure.

Our read

Two of the highest-scoring dog joint supplements we rate. In our view YuMOVE edges it overall: it leads on evidence, where its green-lipped mussel active carries a higher tier than glucosamine, and on safety, while Cosequin answers with a higher active-dose mark. The two tie on ingredient clarity and value.

This verdict is our opinion under the PetScored rubric, not veterinary advice. The exact sub-scores are in the table below; each product’s source confidence and limitations stay on its own scorecard.

Score areaYuMOVE
Joint Care for Adult Dogs
Nutramax
Cosequin DS Plus MSM Chewable Tablets
PetScored ratingYuMOVE7.9Nutramax7.7
Evidence QualityYuMOVE6.5Nutramax5.5
Active DoseYuMOVE8.0Nutramax9.0
Ingredient ClarityYuMOVE9.5Nutramax9.5
Safety & ManufacturingYuMOVE8.8Nutramax7.8
ValueYuMOVE8.0Nutramax8.0

YuMOVE

Joint Care for Adult Dogs

A disclosed green-lipped-mussel-forward chew, NASC-sealed and well priced; a modest GLM dose for a larger dog keeps it Good rather than Strong.

Partially verifiedDogs

Nutramax

Cosequin DS Plus MSM Chewable Tablets

Excellent dose transparency and in-house batch testing on a weakly-evidenced active; in our view it lands Good, not Strong, because glucosamine and chondroitin evidence for osteoarthritis is contested.

Partially verifiedDogs

Comparison scores use the same reconstructed score-event math as the supplement scorecards. Source confidence, unresolved gaps, evidence-library citations, and dose caveats remain attached to each individual scorecard.